- Access through your institution
Abstract:
Ethnopharmacological relevance
Depression, one of the most common psychiatric disorders, is the fourth leading cause of long-term disability worldwide. A series of causes triggered depression, including psychological stress and conflict, as well as biological derangement, among which stress has a pivotal role in the development of depression. Traditional herbal medicine has been used for the treatment of various disorders including depression for a long history with multi-targets, multi-levels and multi-ways, attracting great attention from scholars. Recently, natural products have been commercialized as antidepressants which have become increasingly popular in the world health drug markets. Major research contributions in ethnopharmacology have generated and updated vast amount of data associated with natural products in antidepressant-like activity.
Aims of the review
This review aims to briefly discuss the pathological mechanism, animal models of stress-induced depression, traditional use of herbal medicines and especially recapitulate the natural products with antidepressant activity and their pharmacological functions and mechanism of action, which may contribute to a better understanding of potential therapeutic effects of natural products and the development of promising drugs with high efficacy and low toxicity for the treatment of stress-induced depression.
Materials and methods
The contents of this review were sourced from electronic databases including PubMed, Sci Finder, Web of Science, Science Direct, Elsevier, Google Scholar, Chinese Knowledge On frastructure (CNKI), Wan Fang, Chinese Scientific and Technological Periodical Database (VIP) and Chinese Biomedical Database (CBM). Additional information was collected from Yao Zhi website (//db.yaozh.com/). Data were obtained from April 1992 to June 2021. Only English language was applied to the search. The search terms were ‘stress-induced depression’, ‘pathological mechanism’ in the title and ‘stress’, ‘depression’, ‘animal model’ and ‘natural products’ in the whole text.
Results
Stress-induced depression is related to the monoaminergic system, hypothalamic-pituitary-adrenal (HPA) axis, neuronal plasticity and a series of inflammatory factors. Four main types of animal models of stress-induced depression were represented. Fifty-eight bioactive phytochemical compounds, fifty-six herb medicines and five formulas from traditional Chinese medicine were highlighted, which exert antidepressant effects by inhibiting monoamine oxidase (MAO) reaction, alleviating dysfunction of the HPA axis and nerve injury, and possessing anti-inflammatory activities.
Conclusions
Natural products provide a large number of compounds with antidepressant-like effects, and their therapeutic impacts has been highlighted for a long time. This review summarized the pathological mechanism and animal models of stress-induced depression, and the natural products with antidepressant activity in particular, which will shed light on the action mechanism and clinical potential of these compounds. Natural products also have been a vital and promising source for future antidepressant drug discovery.
Introduction
Depression, a common illness severely limiting psychosocial functioning and diminishing quality of life, affects 350 million people worldwide according to the World Health Organization (WHO) (Malhi and Mann, 2018; Smith, 2014). Moreover, depression is one of the most serious neuropsychiatric disorders accounting for 40.5% of all disability-adjusted life years caused by mental pathologies (Whiteford et al., 2016). Risk factors for occurrence of depression including genetic, immunological and environmental, among which stress is a significant trigger for the onset of depression. Study noted patients with depression experienced 2.5 times more stressors than normal individuals, and 80% of depression cases were preceded by stressful events (Hammen, 2005). Numerous researches revealed prolonged exposure to stress increased vulnerability to anxiety, depression and other mood disorders, accompanying by metabolic syndrome, cardio cerebrovascular disease, memory disorders, cognition, learning disorders and even structural changes in different parts of brain (Seo et al., 2017).
The pathological mechanism of depression is subject to sharply divided opinions. A considerable finding in psychoneuroendocrinology of stress-induced depression is the change of the HPA axis, characterizing elevated levels of corticosterone (CORT) and adrenocorticotrophic hormone (ACTH) in serum (Weger and Sandi, 2018). Moreover, various evidence demonstrates that the increased activity of proinflammatory cytokines has played an important role in stress-induced depression (Lindqvist et al., 2017). Another leading hypothesis on the neurobiological basis of stress-induced depression is the monoamine hypothesis, which contends decreased level of serotonin (5-HT) and norepinephrine (NE) (Charney, 1998). Increasing evidence indicates brain-derived neurotrophic factor (BDNF) controls the process of neurogenesis, which reflects the neuroplasticity hypothesis in stress-induced depression (D'Sa and Duman, 2002). Furthermore, some authorities maintain just as firmly that oxidative stress causes the oxidation of proteins and cell degeneration, relating to the occurrence of depression.
Animal models contribute to understanding the pathological mechanism and drug discovery of diseases. Stress-induced depression related animal models are established on chronic and inescapable stress paradigms. We describe four animal stress models as possible models for human depression. The paradigms, behavioral correlates to depression and potential underlying neurobiological mechanisms were discussed to facilitate possible future therapies for depression. For example, as the most commonly used and effective rodent model of depression, CUMS paradigm is widely applied to evaluate depressive-like behavior (Antoniuk et al., 2019).
Synthesized agents including selective 5-HT reuptake inhibitors (SSRIs), MAO inhibitors, tricyclic antidepressants (TCAs) and atypical antidepressants have been widely clinical used in patients with depression (Duman and Voleti, 2012). Unfortunately, only one-third of patients have beneficial treatment response to these agents complicating by serious adverse side effects of nausea, vomiting, sleep disruption, sedation, sexual dysfunction and weight gain (David and Gourion, 2016; Thanacoody and Thomas, 2005). Thus, it is urgent to seek safer and more effective alternatives against depression.
Traditional medicine such as traditional Chinese medicine, traditional African medicine and Islamic medicine, is widely used to treat mental disorders in Europe or other countries and areas of the world (Kpobi et al., 2019; Mitha, 2020; Qu et al., 2019; Sarris et al., 2011). In support, hypericin, a class of natural flavonoids product that act as the main pharmacologically active components of Hypericum perforatumis (also known as St. John's wort), has been discovered as a novel antidepressant to amelioration depression and is available as an over-the-counter herbal medicine in the United States. In addition, a St. John's wort dietary supplement with antidepressant activity is currently produced. Moreover, Chinese herbal formulas such as Gan-Mai-Da-Zao Decotion, Xiao-Yao-San and Chai-Hu-Shu-Gan-San, have been proved to be effective in treating and improving depressive-like symptoms (Jun et al., 2014; Sun et al., 2018; Yuan et al., 2020).
Several animal experiments and randomized clinical trials have been performed to validate the anti-depressive effects of many herbal medicines or natural products. These investigations provide a scientific rationale and research direction to support the traditional use of herbal medicines. To better understand the potential therapeutic effects of natural products and develop a promising drug with high efficacy and low toxicity for the treatment of stress-induced depression, more and more scientific investigations regard to the research for natural products with antidepressant activities should be carried out. This review summarized the pathological mechanism and animal models of stress-induced depression, and a various of natural products with antidepressant effects, which confirmed the therapeutic potential of natural products and provided a reference for the further development of antidepressants.
Section snippets
Pathological mechanism of stress-induced depression
Stress can be either a triggering or aggravating factor for many diseases and pathological conditions, exerting destructive effects on central nervous system (CNS) and thus leading to memory, cognitive and learning disorders. Moreover, it affects the function of immune system through modulating processes in the CNS and neuroendocrine system, leading to a deleterious effect on cardiovascular system, gastrointestinal (GI) system and endocrine system (Yaribeygi et al., 2017). These changes may
Animal models of stress-induced depression
Establishment of animal models perfectly recapitulating the symptoms of depression is extremely difficult as animals not only lack consciousness of themselves, consideration of others, self-regulatory and self-reflection but also hallmarks of depression such as depressed mood, low self-esteem or suicidality (McArthur and Borsini, 2006). Three eligibility criteria sets for a desirable animal model included face validity, construct validity and predictive validity (Willner, 1984). The stress
Natural products with antidepressant activities
Various active ingredients from natural products are observed to play an important and indispensable role in prevention and treatment of mental disorders (Olfson et al., 2002; Williams et al., 1999), which have attracted increasing attention and may be ideal alternatives for depression treatment. Structural diversity and extensive pharmacological effects are characteristic of natural products, which are not common in synthetic anti-depressant drugs.
Chinese medicine formulas with antidepressant effects
Chinese medicine formulas (TCMFs), in which the interaction of various medicines can improve efficacy and reduce toxicity, have been clinically used for thousands of years in China. Recently, treatment with Chinese medicine formulas against depression is becoming favorable among scholars and researchers. Numerous studies have shown the antidepressant effects of TCMFs focused on regulating monoamines, reestablishing neuronal plasticity, alleviating HPA axis dysfunction and abnormal regulation of
Traditional use of natural products for depression
Among the rich and diverse medicinal plants, herbal medicine is one of the oldest with a history of more than 2000 years. With great structural diversity and extensive biological activity, natural products have been the most productive source of leads for new drugs. As early as the Swiss physician Paracelsus (ca. 1493–1541), traditional European medicine has used Hypericum perforatum L. for centuries as a treatment for psychiatric disorders including neuralgia, anxiety, neurosis and depression (
Toxicological information of natural products
Since the US Congress passed the Dietary Supplement Health and Education Act, the retail sales of herbal products, a subcategory of dietary supplements, have increased by 83% from 2008 to 2018 ($4.8 to $8.8 billion) (Gaston et al., 2020). Although natural products show good and unique effects in the treatment of depression, the duality of drugs, as one of the basic laws of drug action, can likewise be found in natural products. Natural products not only have a good effect on disease prevention,
Conclusions
Stress-induced depression is a prevalent and persistent mental disorder leading to heavy socioeconomic burden and higher suicide rates. Numerous studies have demonstrated that stress-induced depression was in high relationship with the monoaminergic system, HPA axis, neuronal plasticity and a series of inflammatory factors (Farahani et al., 2015). Stress-induced experimental animal models can recapitulate depressive symptoms, analyze the effects of novel antidepressants, and guide the
Author's contributions
Wei Dai collated documents and wrote the manuscript; Xiaolei Sun helped to perform the arrangement of tables and pictures; Kunmiao Feng contributed to the documents download and queried; Lingchuan Xu, Dan Jia and Ting Han contributed significantly to analysis and manuscript preparation.
Declaration of competing interest
The authors declare that they do not have any conflict of interest.
Acknowledgments
This work was supported by National Natural Science Foundation of China (No. 81872953 and 82174091) and Shanghai Pujiang Program (No. 18PJD061).
References (232)
- et al.
On the mechanism of antidepressant-like action of berberine chloride
Eur. J. Pharmacol.
(2008)
- S.K. Kulkarni et al.
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride
Eur. J. Pharmacol.
(2007)
- J.H. Jun et al.
Herbal medicine (Gan Mai Da Zao decoction) for depression: a systematic review and meta-analysis of randomized controlled trials
Maturitas
(2014)
- Z.L. Jin et al.
The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2014)
- Z.L.
Jin et al.
The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor
Eur. Neuropsychopharmacol
(2015)
- W.W. Ji et
al.
Antidepressant-like effect of essential oil of Perilla frutescens in a chronic, unpredictable, mild stress-induced depression model mice
Chin. J. Nat. Med.
(2014)
- N.N. Jain et al.
Clitoria ternatea and the CNS
Pharmacol. Biochem. Behav.
(2003)
- Y.J. Huang et al.
Poria cocos water extract ameliorates the behavioral deficits induced by unpredictable chronic mild stress in rats by down-regulating inflammation
J. Ethnopharmacol.
(2020)
- A. Holmes et al.
Early life genetic, epigenetic and environmental factors shaping emotionality in rodents
Neurosci. Biobehav. Rev.
(2005)
- S. Heinisch et
al.
Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus
Neuroscience
(2009)
The link between childhood trauma and depression: insights from HPA axis studies in humans
Psychoneuroendocrinology
(2008)
Monoamine neurocircuitry in depression and strategies for new treatments
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2013)
Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats
J. Pharmaceut. Biomed. Anal.
(2016)
Stress and brain noradrenaline: a review
Neurosci. Biobehav. Rev.
(1985)
Increased left ventricular mass in hypercortisolemic depressed patients: a hypothesis based on a case series
Med. Hypotheses
(2014)
Antidepressant potential of Uncaria rhynchophylla and its active flavanol, catechin, targeting melatonin receptors
J. Ethnopharmacol.
(2019)
Orcinol glucoside produces antidepressant effects by blocking the behavioural and neuronal deficits caused by chronic stress
Eur. Neuropsychopharmacol
(2014)
Natural" is not synonymous with "Safe": toxicity of natural products alone and in combination with pharmaceutical agents
Regul. Toxicol. Pharmacol.
(2020)
Cipadesin A, a bioactive ingredient of Xylocarpus granatum, produces antidepressant-like effects in adult mice
Neurosci. Lett.
(2016)
Hypericum perforatum (St John's wort) beyond depression: a therapeutic perspective for pain conditions
J. Ethnopharmacol.
(2017)
The effect of Hypericum perforatum on postmenopausal symptoms and depression: a randomized controlled trial
Compl. Ther. Med.
(2019)
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
Trends Neurosci.
(2012)
Metabonomic identification of the effects of the Zhimu-Baihe saponins on a chronic unpredictable mild stress-induced rat model of depression
J. Pharmaceut. Biomed. Anal.
(2016)
Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2006)
Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: a randomized, placebo-controlled study
Maturitas
(2017)
[Antidepressant and tolerance: determinants and management of major side effects]
Encephale
(2016)
From forest to pharmacy: should we be depressed about a sustainable Griffonia simplicifolia (Fabaceae) seed supply chain?
J. Ethnopharmacol.
(2021)
Learned helplessness: validity and reliability of depressive-like states in mice
Brain Res Brain Res Protoc
(2005)
Fructo-oligosaccharides from Morinda officinalis remodeled gut microbiota and alleviated depression features in a stress rat model
Phytomedicine
(2020)
Saikosaponin A attenuates perimenopausal depression-like symptoms by chronic unpredictable mild stress
Neurosci. Lett.
(2018)
Gardenia jasminoides Ellis: ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine
J. Ethnopharmacol.
(2020)
Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons
Brain Res.
(1996)
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Psychoneuroendocrinology
(2015)
Study on antidepressant activity of chiisanoside in mice
Int. Immunopharm.
(2018)
Immunomodulatory effects of Sceletium tortuosum (Trimesemine) elucidated in vitro: implications for chronic disease
J. Ethnopharmacol.
(2018)
Evolvulus alsinoides (convolvulaceae): an American herb in the old world
J. Ethnopharmacol.
(2008)
Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability
Neurosci. Biobehav. Rev.
(2019)
The glucocorticoid receptor: pivot of depression and of antidepressant treatment?
Psychoneuroendocrinology
(2011)
A review on therapeutic potential of Nigella sativa: a miracle herb
Asian Pac J Trop Biomed
(2013)
Resveratrol and dimethyl fumarate ameliorate depression-like behaviour in a rat model of chronic unpredictable mild stress
Brain Res.
(2018)
Potential antidepressant activity of Areca catechu nut via elevation of serotonin and noradrenaline in the hippocampus of rats
Phytother Res.
(2013)
Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]
BMC Compl. Alternative Med.
(2004)
Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial
Phytother Res.
(2005)
Pharmacological and toxicological properties of Nigella sativa
Phytother Res.
(2003)
Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study
Alternative Ther. Health Med.
(2012)
Exposure to early adversity: points of cross-species translation that can lead to improved understanding of depression
Dev. Psychopathol.
(2015)
Stress management and the role of Rhodiola rosea: a review
Int. J. Psychiatr. Clin. Pract.
(2018)
Rodent models of depression: learned helplessness induced in mice
Curr Protoc Neurosci Chapter
(2001)
A systematic review of St. John's wort for major depressive disorder
Syst. Rev.
(2016)
Review-Therapeutic implications of Nigella sativa against cancer metastasis
Pak. J. Pharm. Sci.
(2016)
Cited by (4)
Recommended articles (6)
© 2021 Elsevier B.V. All rights reserved.